Yes / Platinum drugs are widely used for cancer treatment. Other precious metals are promising, but their clinical progress depends on achieving different mechanisms of action to overcome Pt-resistance. Here, we evaluate 13 organo-Os complexes: 16-electron sulfonyl-diamine catalysts [(η6-arene)Os(N,N′)], and 18-electron phenylazopyridine complexes [(η6-arene)Os(N,N’)Cl/I]+ (arene = p-cymene, biphenyl, or terphenyl). Their antiproliferative activity does not depend on p21 or p53 status, unlike cisplatin, and their selective potency toward cancer cells involves the generation of reactive oxygen species. Evidence of such a mechanism of action has been found both in vitro and in vivo. This work appears to provide the first study of osmium complexes in the zebrafish model, which has been shown to closely model toxicity in humans. A fluorescent osmium complex, derived from a lead compound, was employed to confirm internalization of the complex, visualize in vivo distribution, and confirm colocalization with reactive oxygen species generated in zebrafish. / Wellcome Trust (grant no. 107691/Z/15/Z), ERC (grant nos. 247450, 324594), Science City (AWM and ERDF), WCPRS and Bruker Daltonics (Studentship for JPCC), Mike and Enfys Bagguley, and EPSRC (Studentship for HEB, and grant no. EP/F034210/1).

Dravet Syndrome (DS) is a pediatric epilepsy disorder. Individuals with DS are at increased risk of Sudden Unexpected Death in Epilepsy (SUDEP). One mechanism implicated in the pathology of SUDEP is cardiac arrhythmias. A central element involved in cardiac regulation is mitochondria. In the heart, mitochondria maintain cardiomyocyte energy (ATP) generation and ion homeostasis but also produce harmful reactive oxygen species (ROS) byproducts. We hypothesized that deficits in cardiac mitochondria could underlie arrhythmias and SUDEP in two independent mouse models of DS. Mitochondria produce ATP through the mitochondrial respiratory chain, also called electron transport chain, comprised of a series of large, multimeric complexes (labeled I-IV) coupled to the activity of an ATP synthase. We first simultaneously analyzed electron transport chain activity and ROS production via Complex I- and Complex II-linked respiratory pathways in cardiac mitochondria isolated from DS mouse hearts. ROS produced as a byproduct of ATP generation is scavenged by cellular antioxidant systems, primarily glutathione in the heart. Therefore, we next subjected isolated cardiomyocytes to diamide, which oxidizes thiol-based antioxidants, to determine ROS scavenging ability in DS hearts. Furthermore, isolated hearts were also perfused with diamide via Langendorff assays to test for arrhythmia susceptibility in the presence of oxidative stress. Another essential function of mitochondria is buffering ions like Ca2+. While fatal at high concentrations, Ca2+ stimulates mitochondrial ATP production at physiological levels. We determined if cardiac mitochondria from DS hearts have altered levels of Ca2+ uptake (via the mitochondrial Ca2+ uniporter) and retention. We also investigated if mitochondrial energetic capacity was impacted by Ca2+ dysregulation. Furthermore, due to its impacts on ATP, mitochondrial Ca2+ sequestration is an essential physiological mechanism linking the sympathetic drive to the heart with cardiac output. We tested the response of DS hearts to norepinephrine, a sympathetic agonist, to determine if these conditions caused increased vulnerability to arrhythmias. Overall, our results indicate that these models of DS have distinct energetic and antioxidant phenotypes that may also be impacted by biological sex. Considering these differences may be necessary when tailoring treatment and preventing SUDEP in the clinical practice of DS patients with different etiologies.

The aim of this thesis is to investigate molecular mechanism of reactive oxygen species production by flavin dehydrogenases mitochondrial glycerol-3-phosphate dehydrogenase (mGPDH) and succinate dehydrogenase (SDH). Together, they represent important source of reactive oxygen species in mammalian mitochondria, but the mechanism of electron leak is still poorly understood. Because mechanisms of reactive oxygen species production by other complexes of respiratory chain are better characterized, they can serve as case studies to get insight into mechanisms of reactive oxygen species by flavin dehydrogenases. Relevant knowledge is therefore summarized in the first part of the thesis. To study the production of reactive oxygen species by the isolated flavin dehydrogenases, we used brown adipose tissue mitochondria solubilized by digitonin as a model. Enzyme activity measurements, hydrogen peroxide production studies by Amplex UltraRed fluorescence and luminol luminescence revealed flavin as the most likely source of electron leak in SDH under in vivo conditions, while we propose coenzyme Q binding site as the site of reactive oxygen species production in the case of mGPDH. Distinct mechanism of this production by the two dehydrogenases is also apparent from induction of reactive oxygen species...

No description available.

Indiana University-Purdue University Indianapolis (IUPUI) / Tobacco smoking is considered a major modifiable risk factor for periodontal disease. Tobacco contains about 6700 compounds and almost 4000 compounds of these have been identified in tobacco smoke. Nicotine is the addictive ingredient in tobacco and has been shown to affect multiple cellular processes. Cigarette smoke condensate (CSC) is the particulate matter of smoke. It is believed to be a powerful inducer of inflammatory responses. Neutrophils are the first line of host defense and are critical cells in the maintenance of periodontal health through their role in the control of bacteria, but they can also contribute to the progression of periodontal disease by the production and release of reactive oxygen species (ROS). Virulence factors from periodontal pathogens, such as Porphyromonas gingivalis (P. gingivalis), stimulate the respiratory burst of neutrophils. In this dissertation, three studies aimed at understanding the oxidative activity of neutrophils when stimulated with either nicotine, cigarette smoke condensate (CSC) or four other components of tobacco smoke (2-naphthylamine, hydroquinone, acrolein, and acetaldehyde) with or without P. gingivalis supernatant. The release of matrix metalloproteinase-9 (MMP-9) was also examined. ROS production increased significantly when the neutrophils were stimulated with nicotine. P. gingivalis induced the maximum ROS production when compared to all the other components examined. The combination of nicotine and P. gingivalis did not have an additive effect on ROS production. Nicotine significantly increased the MMP-9 release from the neutrophils. On the contrary, CSC inhibited ROS production at all the concentrations examined. The combination of CSC and P. gingivalis resulted in the inhibition of ROS production. MMP-9 release was also increased from the CSC-treated neutrophils. The four other tobacco smoke components examined affected ROS production and MMP-9 release differently. These projects demonstrated that CSC inhibited the ROS production from neutrophils, which can be attributed to several components in tobacco smoke that may include acrolein and hydroquinone. More research is needed to determine the mechanisms of inhibition and if other tobacco components are involved in ROS inhibition

Das Rett-Syndrom ist eine postnatale neurologische Entwicklungsstörung, der eine Mutation im Methyl-CPG-bindenden Protein 2 (MECP2) zugrunde liegt. Es betrifft überwiegend Mädchen und geht mit kognitiven Beeinträchtigungen, motorischen Stereotypien und Atmungsstörungen einher. Es existieren vielfältige Hinweise dafür, dass die Pathogenese des Rett-Syndroms im Zusammenhang mit einer beeinträchtigten Mitochondrienfunktion steht. Genetische Untersuchungen des Rett-Genoms zeigten, dass eine Untereinheit des Komplex III der Atmungskette dysreguliert ist und die innere Mitochondrienmembran ein Protonenleck aufweist. Weiterhin fanden sich Hinweise für erhöhten oxidativen Stress in Blut- und Liquoruntersuchungen. Um den intrazellulären Redox-Status zu quantifzieren, wurde die genetisch kodierte optische Sonde roGFP1 verwendet, die semiquantitative Messungen reaktiver Sauerstoffspezies ermöglichte. Es zeigte sich, dass Mecp2(-/y)-Hirnschnitte bereits unter Ruhebedingungen erhöhtem oxidativen Stress ausgesetzt sind. Auf der Suche nach der Ursache wurden die intrazellulären antioxidativen Schutzenzyme Superoxid-Dismutase und Katalase sowie das Glutathionsystem überprüft. Alle drei Enzymsysteme zeigten Funktionsstörungen und waren nicht in der Lage, extern applizierten oxidativen Stress im gleichen Umfang zu kompensieren wie die Enzyme der Wildtyp-Vergleichsgruppe. Um die zytosolischen Redox-Verhältnisse zu beeinflussen, wurden Untersuchungen mit den Antioxidantien Ascorbat, Trolox und Melatonin vorgenommen. Dabei zeigte sich, dass Antioxidantien eine potentielle pharmakologische Maßnahme darstellen, um die zu oxidativen Verhältnissen verschobene Redox-Homöostase in Mecp2(-/y)-Hippokampi zu senken und folglich zu normalisieren. Vor allem das Vitamin E-Derivat Trolox stellte sich als wirkungsvoller Radikalfänger heraus und bietet sich für weitere detaillierte Untersuchungen hinsichtlich einer therapeutischen Option des Rett-Syndroms an. Die externe Störung der mitochondrialen Funktion durch die Induktion einer transienten Hypoxie sowie die gezielte Inhibition verschiedener Atmungskettenkomplexe zeigte eine deutlich erhöhte Hypoxieempfindlichkeit der Mecp2(-/y)-Hippokampi und war mit einer erhöhten ROS-Produktion verbunden. In der Arbeit gelang es erstmals, die bereits mehrfach postulierte Störung der Redox-Homöostase im Rett-Syndrom direkt auf zellulärer Ebene nachzuweisen. Die erhobenen Befunde liefern mögliche mechanistische Erklärungsansätze für die Störung der synaptischen Plastizität im Rett-Syndrom, da es klare Verbindungen zwischen dem zellulären Redox-Status und dem Kalziumhaushalt gibt, der durch redoxsensitive Proteine mitreguliert wird. Somit konnte eine zentrale Dysregulation der Erkrankung identifziert werden, die unter Umständen auch neue pharmakologische Angriffspunkt aufzeigt, um die Symptomatik des Rett-Syndroms zu mildern.

Systemic acquired resistance (SAR) is a form of inducible defense response triggered upon localized infection that confers broad-spectrum disease resistance against secondary infections. Several factors are known to regulate SAR and these include phenolic phytohormone salicylic acid (SA), phosphorylated sugar glycerol-3-phosphate (G3P), and dicarboxylic acid azelaic acid (AzA). This study evaluated a role for free radicals nitric oxide (NO) and reactive oxygen species (ROS) in SAR. Normal accumulation of both NO and ROS was required for normal SAR and mutations preventing NO/ROS accumulation and/or biosynthesis compromised SAR. A role for NO and ROS was further established using pharmacological approaches. Notably, both NO and ROS conferred SAR in a concentration dependent manner. This was further established using genetic mutants that accumulated high levels of NO. NO/ROS acted upstream of G3P and in parallel to SA. Collectively, these results suggest that NO and ROS are essential components of the SAR pathway.

In many chronic inflammatory diseases, patients suffer from skeletal muscle weakness, exacerbating their symptoms. Serum levels of tumor necrosis factor-alpha (TNF) and sphingomyelinase are increased, suggesting their possible role in the progression of this weakness. This dissertation focuses on the role that reactive oxygen species (ROS) and nitric oxide (NO) play in mediating TNF-induced skeletal muscle weakness and to what extent sphingolipid signaling mediates cellular response to TNF. The first aim of this work was to identify which endogenous oxidant species stimulated by TNF contributes to skeletal muscle weakness. In C57BL/6 mice (n=38), intraperitoneal injection of TNF elicited a 25% depression of diaphragm contractile function. In separate experiments, diaphragm fiber bundles harvested from mice (n=39) and treated with TNF ex vivo showed a 38% depression of contractile function compared to untreated controls. Using ROS and NO-sensitive fluorescence microscopy in parallel with a genetic knockout animal model, TNF-induced contractile dysfunction was found to be mediated by NO generated by a specific isoform of nitric oxide synthase (NOS), nNOS. Basal levels of ROS were necessary co-mediators, but were not sufficient to elicit TNF-induced diaphragm weakness. The second aim of this dissertation was to investigate the extent to which sphingolipids could serve as a signaling cascade post-TNF stimulus leading to the generation of NO in skeletal muscle. The effects of TNF exposure in C2C12 skeletal muscle cells were studied in vitro using mass spectroscopy to measure sphingolipid metabolism and fluorescent microscopy to quantify oxidant production. TNF exposure was associated with significant mean increases in sphingosine (+52%), general oxidant activity (+33%), and NO production (+14%). These increases were due to specific modulation of nNOS as demonstrated by siRNA knockdown of neutral ceramidase and nNOS, and confirmed by pharmacologic inhibition using N-Oleoylethanolamine and di-methylsphingosine. In summary, these findings confirm NO as a major causative oxidant contributing to TNF’s deleterious phenotype in skeletal muscle. Moreover, the work suggests a new role for sphingosine in skeletal muscle and warrants further study of the enzymatic regulation of sphingosine to advance the discovery of new therapies for patients suffering from chronic inflammation.

Tyrosyl phosphorylation plays an important role in many fundamental cellular processes, including cell growth, differentiation and proliferation. The levels of phosphotyrosine (pY) are regulated by the opposing actions of protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs). A limitation to understanding the roles of PTPs in physiological and pathological cell signaling has been the absence of global proteomic approaches that enable the systematic and comprehensive analysis of PTP expression, regulation and function. This dissertation describes the development and application of novel proteomic methodologies that permit the global analysis of PTP expression (qPTPome), regulation (by oxidation and nitrosylation; q-oxPTPome) and substrates/binding proteins. These methods provide a workflow to begin assessing PTP function at a systems level, rather than its current targeted format. Application of these techniques will provide invaluable information to begin bridging the gap in our understanding of PTP and PTK function in normal and malignant cell signaling.

Chemotherapy, employing single-molecule or multidrug concoctions inspired by the diverse repository of plant chemicals, has been the mainstay of cancer treatment for years. However, isolating single molecules has proven to be expensive along with limited therapeutic window and toxicity. On the other hand, whole foods, while preserving the natural complex balance between their constituent phytochemicals and being non-toxic, have proven to impart better disease-fighting efficacies, thus leading to an increased focus on dietary interventions to both treat and prevent cancer. Owing to the complex interactions between their constituent phytochemicals, several dietary agents have been investigated for their therapeutic and preventive efficacies. However, due to lack of emphasis on confounding factors like bioavailability, absorption, metabolism, and excretion, essentially driven by phytocomplexity, incorporation of whole foods in therapeutic regimen has not been successful. This thesis exemplifies the need to investigate factors associated with the limitations in the current approach with respect to dietary agents. Bioactivity-guided fractionation of sweet potato greens extract (SPGE) led to the identification of ~100-fold more potent fraction in vitro. However, this efficacy could not be translated in vivo. We also studied whole ginger extract (GE) for its in vitro and in vivo prostate tumor growth-inhibitory and apoptosis-inducing effects. In addition, GE proved to be more efficacious as compared to its individual most-active constituents owing to the differences in their pharmacokinetic (PK) and bioavailability measurements. Hence, these studies emphasize the crucial role of synergistic/additive interactions among the constituents of whole foods in successful translation of their therapeutic benefits. Another factor that seeks further attention is the unique cellular mechanisms engaged by these phytochemicals to confer their remarkable effects. Phenolic compounds, the most-abundant of all phytochemicals, are well known for their antioxidant properties and act via reactive oxygen species (ROS)-mediated mechanisms. We however assert the underappreciated xenohormetic prooxidant role of phenolics, where cancer cell death is caused by induction of intolerable levels of ROS. We demonstrated that a Piper betel constituent, hydroxychavicol (HC), mediates cytotoxicity via ROS-induced DNA-damage. This thesis thus provides compelling grounds for future preclinical studies to validate their potential usefulness for cancer management.